Alvim R - Search Results

1

Developments in Vascular-Targeted Photodynamic Therapy for Urologic Malignancies.

Nogueira L, Tracey AT, Alvim R, Reisz P, Scherz A, Coleman JA, Kim K. Nogueira L, et al. Among authors: alvim r. Molecules. 2020 Nov 19;25(22):5417. doi: 10.3390/molecules25225417. Molecules. 2020. PMID: 33228126 Free PMC article. Review.

2

The potential risk of tumor progression after use of dehydrated human amnion/chorion membrane allograft in a positive margin resection model.

Alvim RG, Hughes C, Somma A, Nagar KK, Wong NC, La Rosa S, Monette S, Kim K, Coleman JA. Alvim RG, et al. Ther Adv Urol. 2019 Mar 29;11:1756287219837771. doi: 10.1177/1756287219837771. eCollection 2019 Jan-Dec. Ther Adv Urol. 2019. PMID: 30956688 Free PMC article.

3

Phase III Trial of Intravenous Mannitol Versus Placebo During Nephron-sparing Surgery: Post Hoc Analysis of 3-yr Outcomes.

Wong NC, Alvim RG, Sjoberg DD, Shingarev R, Power NE, Spaliviero M, Murray KS, Benfante NE, Hakimi AA, Russo P, Coleman JA. Wong NC, et al. Among authors: alvim rg. Eur Urol Focus. 2019 Nov;5(6):977-979. doi: 10.1016/j.euf.2019.04.003. Epub 2019 Apr 25. Eur Urol Focus. 2019. PMID: 31029560 Free PMC article. Clinical Trial.

4

Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer.

Lebdai S, Gigoux M, Alvim R, Somma A, Nagar K, Azzouzi AR, Cussenot O, Merghoub T, Wolchok JD, Scherz A, Kim K, Coleman J. Lebdai S, et al. Among authors: alvim r. Oncoimmunology. 2019 Mar 28;8(6):e1581528. doi: 10.1080/2162402X.2019.1581528. eCollection 2019. Oncoimmunology. 2019. PMID: 31069149 Free PMC article.

5

Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model.

Alvim R, Nagar K, Das S, Lebdai S, Wong N, Somma A, Hughes C, Thomas J, Monette S, Scherz A, Kim K, Grimm J, Coleman JA. Alvim R, et al. Eur Urol Focus. 2021 Mar;7(2):472-478. doi: 10.1016/j.euf.2019.06.008. Epub 2019 Jun 18. Eur Urol Focus. 2021. PMID: 31227464 Free PMC article.

6

Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts.

Kim K, Hu W, Audenet F, Almassi N, Hanrahan AJ, Murray K, Bagrodia A, Wong N, Clinton TN, Dason S, Mohan V, Jebiwott S, Nagar K, Gao J, Penson A, Hughes C, Gordon B, Chen Z, Dong Y, Watson PA, Alvim R, Elzein A, Gao SP, Cocco E, Santin AD, Ostrovnaya I, Hsieh JJ, Sagi I, Pietzak EJ, Hakimi AA, Rosenberg JE, Iyer G, Vargas HA, Scaltriti M, Al-Ahmadie H, Solit DB, Coleman JA. Kim K, et al. Among authors: alvim r. Nat Commun. 2020 Apr 24;11(1):1975. doi: 10.1038/s41467-020-15885-7. Nat Commun. 2020. PMID: 32332851 Free PMC article.

7

Neoadjuvant vascular-targeted photodynamic therapy improves survival and reduces recurrence and progression in a mouse model of urothelial cancer.

Rosenzweig B, Corradi RB, Budhu S, Alvim R, Recabal P, La Rosa S, Somma A, Monette S, Scherz A, Kim K, Coleman JA. Rosenzweig B, et al. Among authors: alvim r. Sci Rep. 2021 Mar 1;11(1):4842. doi: 10.1038/s41598-021-84184-y. Sci Rep. 2021. PMID: 33649388 Free PMC article.

8

A comparison of oncologic and functional outcomes in patients with pt3a renal cell carcinoma treated with partial and radical nephrectomy.

Alvim R, Tin A, Nogueira L, Lebdai S, Wong N, Takeda T, Assel M, Hakimi AA, Touijer K, Russo P, Coleman J. Alvim R, et al. Int Braz J Urol. 2021 Jul-Aug;47(4):777-783. doi: 10.1590/S1677-5538.IBJU.2020.0149. Int Braz J Urol. 2021. PMID: 33848068 Free PMC article.

9

Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model.

Alvim RG, Georgala P, Nogueira L, Somma AJ, Nagar K, Thomas J, Alvim L, Riegel A, Hughes C, Chen J, Reis AB, Lebdai S, Scherz A, Zanganeh S, Gardner R, Kim K, Coleman JA. Alvim RG, et al. Among authors: alvim l. Molecules. 2021 Jun 19;26(12):3744. doi: 10.3390/molecules26123744. Molecules. 2021. PMID: 34205347 Free PMC article.

10

Functional and Oncological Outcomes of Renal Surgery for Hilar Tumors: Informing the Decisions in Risk-Adapted Management.

Alvim RG, Tin AL, Nogueira L, Wong NC, Fonseca RC, Sjoberg DD, Hakimi AA, Touijer KA, Russo P, Coleman JA. Alvim RG, et al. Urology. 2021 Nov;157:174-180. doi: 10.1016/j.urology.2021.07.014. Epub 2021 Jul 29. Urology. 2021. PMID: 34331997 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page